pmid,title,journal,year,drug,disease
38195767,Exosomal microRNAs as biomarkers for viral replication in tofacitinib-treated rheumatoid arthritis patients with hepatitis C.,Scientific reports,2024,Tofacitinib,Hepatitis C
36091777,The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies.,Frontiers in pharmacology,2022,Tofacitinib,Hepatitis C
35069993,Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disorders.,World journal of hepatology,2021,Tofacitinib,Hepatitis C
33470695,Review article: safety of new biologic agents for inflammatory bowel disease in the liver.,European journal of gastroenterology & hepatology,2021,Tofacitinib,Hepatitis C
30606739,"Comparisons of hepatitis C viral replication in patients with rheumatoid arthritis receiving tocilizumab, abatacept and tofacitinib therapy.",Annals of the rheumatic diseases,2019,Tofacitinib,Hepatitis C
28780423,Cinnamic acid derivatives inhibit hepatitis C virus replication via the induction of oxidative stress.,Antiviral research,2017,Tofacitinib,Hepatitis C
27931982,JAK-inhibitor tofacitinib suppresses interferon alfa production by plasmacytoid dendritic cells and inhibits arthrogenic and antiviral effects of interferon alfa.,Translational research : the journal of laboratory and clinical medicine,2017,Tofacitinib,Hepatitis C
27708965,Viral hepatitis screening guideline before biological drug use in rheumatic patients.,European journal of rheumatology,2016,Tofacitinib,Hepatitis C
